Literature DB >> 9486466

Non-Hodgkin's lymphoma and family history of malignant tumors in a case-control study (United States).

K Zhu1, R S Levine, Y Gu, E A Brann, I Hall, L S Caplan, M K Baum.   

Abstract

Using data from a case-control study in the United States (the Selected Cancers Study), we examined the relationship between non-Hodgkin's lymphoma (NHL) and family history of different cancers. Cases were 1,511 men aged 31 to 59 years and diagnosed pathologically with non-Hodgkin's lymphoma during 1984-88. Controls were men, frequency-matched to cases by age range and cancer registry (n = 1,910). All study subjects with acquired immunodeficiency syndrome were excluded from analyses. Our results showed that the risk of NHL is associated with a history of lymphoma (odds ratio [OR] = 3.0, 95 percent confidence interval [CI] = 1.7-5.2) and hematologic cancer (OR = 2.0, CI = 1.2-3.4) in first-degree relatives after adjustment for age, ethnic background, and educational level. Further analyses were performed for the subgroups defined by age at diagnosis (younger than 45 years cf 45 years or older). The association of NHL with a family history of lymphoma and hematologic cancer was found primarily among men aged 45 and older (OR = 4.1, CI = 1.9-8.8 for lymphoma and OR = 2.3, CI = 1.3-4.0 for hematologic cancer). The association among men aged 45 and older did not vary by whether or not there were any familial patients diagnosed at the age of 45 or older. No significant associations could be found for a family history of lung cancer, breast cancer, prostate cancer, colon cancer, skin cancer, liver cancer, stomach cancer, brain cancer, thyroid cancer, or myeloma. This study suggests that the familial risk of NHL is influenced primarily by hematolymphoproliferative malignancies rather than other cancers. The familial effects of hematolymphoproliferative malignancies may be stronger for men aged 45 to 59, compared with those aged 31 to 44.

Entities:  

Mesh:

Year:  1998        PMID: 9486466     DOI: 10.1023/a:1008853421083

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  8 in total

1.  Running in the family: MALT lymphoma and autoimmune disease in mother and daughter.

Authors:  Barbara Kiesewetter; Marlene Troch; Leonhard Müllauer; Markus Raderer
Journal:  World J Gastrointest Oncol       Date:  2012-02-15

2.  Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph).

Authors:  Sophia S Wang; Susan L Slager; Paul Brennan; Elizabeth A Holly; Silvia De Sanjose; Leslie Bernstein; Paolo Boffetta; James R Cerhan; Marc Maynadie; John J Spinelli; Brian C H Chiu; Pier Luigi Cocco; Fiona Mensah; Yawei Zhang; Alexandra Nieters; Luigino Dal Maso; Paige M Bracci; Adele Seniori Costantini; Paolo Vineis; Richard K Severson; Eve Roman; Wendy Cozen; Dennis Weisenburger; Scott Davis; Silvia Franceschi; Carlo La Vecchia; Lenka Foretova; Nikolaus Becker; Anthony Staines; Martine Vornanen; Tongzhang Zheng; Patricia Hartge
Journal:  Blood       Date:  2006-12-21       Impact factor: 22.113

3.  Increased frequency of hematopoietic malignancies in relatives of patients with lymphoid neoplasms: a French case-control study.

Authors:  Sara Villeneuve; Laurent Orsi; Alain Monnereau; Christian Berthou; Pierre Fenaux; Gerald Marit; Pierre Soubeyran; Françoise Huguet; Noël Milpied; Michel Leporrier; Denis Hemon; Xavier Troussard; Jacqueline Clavel
Journal:  Int J Cancer       Date:  2009-03-01       Impact factor: 7.396

Review 4.  Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  A J Swerdlow
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-07       Impact factor: 9.236

5.  Survival patterns among lymphoma patients with a family history of lymphoma.

Authors:  Lesley A Anderson; Ruth M Pfeiffer; Joshua S Rapkin; Gloria Gridley; Lene Mellemkjaer; Kari Hemminki; Magnus Björkholm; Neil E Caporaso; Ola Landgren
Journal:  J Clin Oncol       Date:  2008-07-07       Impact factor: 44.544

6.  Different role of tumor necrosis factor-α polymorphism in non-Hodgkin lymphomas among Caucasian and Asian populations: a meta-analysis.

Authors:  Kan Zhai; Jie Ding; Yan Zhou
Journal:  Int J Mol Sci       Date:  2014-05-05       Impact factor: 5.923

7.  Familial Aggregation of Non-Hodgkin's Lymphoma (NHL). A Case Report.

Authors:  Sandra Scm Loves; Lieuwe de Haan; Simon Mgj Daenen
Journal:  Hered Cancer Clin Pract       Date:  2006-08-15       Impact factor: 2.857

8.  Family history of haematopoietic malignancies and non-Hodgkin's lymphoma risk in the California Teachers Study.

Authors:  Y Lu; J Sullivan-Halley; W Cozen; E T Chang; K Henderson; H Ma; D Deapen; C Clarke; P Reynolds; S L Neuhausen; H Anton-Culver; G Ursin; D West; L Bernstein
Journal:  Br J Cancer       Date:  2009-01-20       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.